IEM CAS is part of the newly established National Cancer Research Institute (NÚVR)
Published 27. 09. 2022
Scientists would like to improve the diagnosis and treatment of cancer in the future at the newly established National Institute for Cancer Research (NÚVR). The institute will connect 71 research teams from 11 centres in Prague, Olomouc and Brno. The European Union will fund this project with an amount of CZK 1.4 billion within the EXCELES programme of the Ministry of Education, Youth and Sports of the Czech Republic.
The research teams from the Institute of Experimental Medicine CAS, the Institute of Organic Chemistry and Biochemistry CAS, the Institute of Molecular Genetics CAS, the Institute of Biotechnology CAS and the other academic, clinical and university centres will participate in this project.
The project will also provide new patents, certified methods or expert recommendations. All these results should enable significant innovations in cancer diagnosis and treatment. Approximately one-third of the project budget will be allocated to investment development activities, which include the construction of superclean clinical spaces for the production of gene therapy medicine.
"The NÚVR is the largest project of Czech academic oncology. It creates a network of excellent institutes that can cooperate effectively and achieve better results. Similarly, in our clinical oncology, there is a nationwide network of comprehensive cancer centres, which are interconnected by certain rules and communicate with each other," says Prof. Aleksi Šedo, MD, DrSc. - the principal coordinator of the NÚVR.
You can find more information on theCAS website (available only in Czech).